{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:34:18Z","timestamp":1787009658395,"version":"build-2736575974"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Myositis is a heterogeneous family of inflammatory myopathies. We sought to define the differential expression of cytokines, cytokine receptors and immune checkpoint genes in muscle biopsies from patients with different forms of myositis in order to characterize patterns of inflammation in each.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bulk RNA-sequencing was performed on muscle biopsy samples from 669 patients, including 105 with DM, 80 with immune-mediated necrotizing myopathy (IMNM), 65 with anti-synthetase syndrome, 53 with IBM, 19 with anti-PM\/Scl myositis, 310 with other inflammatory or genetic myopathies and 37 controls with normal tissue (NT). Myositis clinical groups and autoantibody subgroups were analysed separately. Expression data were analysed for 338 genes encoding cytokines, cytokine receptors and immune checkpoints. Myositis group-specific genes were identified from this list by finding genes that were specifically differentially expressed in one group compared with all samples and compared with NT (\u03b1\u2009&amp;lt;\u20090.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>IBM patients had the most differentially overexpressed genes (71) among all clinical groups, including 37 that were IBM-specific. Among the top genes were several involved in type 1 inflammation, including CCL5, CXCR3, CCR5, CXCL9 and IFNG. Anti-Jo1 and anti-PM\/Scl patients exhibited differential overexpression of a similar set of genes, while DM patients exhibited differential overexpression of a different set of genes involved in type 1 inflammation. IMNM patients had the least number of differentially overexpressed genes with no predominant inflammatory pattern.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Each myositis clinical group and autoantibody subgroup had differentially overexpressed inflammatory mediators, including a strong type 1 inflammatory gene signature in IBM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf346","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T07:56:41Z","timestamp":1750319801000},"page":"5751-5760","source":"Crossref","is-referenced-by-count":6,"title":["Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis"],"prefix":"10.1093","volume":"64","author":[{"given":"Raphael A","family":"Kirou","sequence":"first","affiliation":[{"name":"Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health , Bethesda, MD,","place":["USA"]},{"name":"College of Medicine, State University of New York Downstate Health Sciences University , Brooklyn, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iago","family":"Pinal-Fernandez","sequence":"additional","affiliation":[{"name":"Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health , Bethesda, MD,","place":["USA"]},{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Casal-Dominguez","sequence":"additional","affiliation":[{"name":"Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health , Bethesda, MD,","place":["USA"]},{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Pak","sequence":"additional","affiliation":[{"name":"Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health , Bethesda, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Preusse","sequence":"additional","affiliation":[{"name":"Department of Neurology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health (BIH) , Berlin,","place":["Germany"]},{"name":"Department of Neuropathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health (BIH) , Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilbe","family":"Dari","sequence":"additional","affiliation":[{"name":"Department of Neurology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health (BIH) , Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Del Orso","sequence":"additional","affiliation":[{"name":"Genomic Technology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health , Bethesda, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Naz","sequence":"additional","affiliation":[{"name":"Genomic Technology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health , Bethesda, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamima","family":"Islam","sequence":"additional","affiliation":[{"name":"Genomic Technology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health , Bethesda, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Gutierrez-Cruz","sequence":"additional","affiliation":[{"name":"Genomic Technology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health , Bethesda, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-1236","authenticated-orcid":false,"given":"Elie","family":"Naddaf","sequence":"additional","affiliation":[{"name":"Division of Neuromuscular Medicine, Department of Neurology, Mayo Clinic , Rochester, MN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-5697","authenticated-orcid":false,"given":"Teerin","family":"Liewluck","sequence":"additional","affiliation":[{"name":"Division of Neuromuscular Medicine, Department of Neurology, Mayo Clinic , Rochester, MN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health (BIH) , Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Selva-O\u2019Callaghan","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d\u2019Hebron General Hospital, Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C","family":"Milisenda","sequence":"additional","affiliation":[{"name":"Muscle Research Unit, Internal Medicine Service, Hospital Clinic; Barcelona University; CIBERER and IDIBAPS ; Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L","family":"Mammen","sequence":"additional","affiliation":[{"name":"Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health , Bethesda, MD,","place":["USA"]},{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["USA"]},{"name":"Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"2025110820513792500_keaf346-B1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O\u2019Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"2025110820513792500_keaf346-B2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1136\/annrheumdis-2019-216599","article-title":"Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis","volume":"79","author":"Pinal-Fernandez","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025110820513792500_keaf346-B3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","article-title":"The 3 major types of innate and adaptive cell-mediated effector immunity","volume":"135","author":"Annunziato","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2025110820513792500_keaf346-B4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11926-024-01164-7","article-title":"Recent updates on the pathogenesis of inflammatory myopathies","volume":"26","author":"Musai","year":"2024","journal-title":"Curr Rheumatol Rep"},{"key":"2025110820513792500_keaf346-B5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","article-title":"Inclusion body myositis: clinical features and pathogenesis","volume":"15","author":"Greenberg","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2025110820513792500_keaf346-B6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.59.8.1170","article-title":"Molecular profiles of inflammatory myopathies","volume":"59","author":"Greenberg","year":"2002","journal-title":"Neurology"},{"key":"2025110820513792500_keaf346-B7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/art.40800","article-title":"Muscle expression of Type I and Type II interferons is increased in juvenile dermatomyositis and related to clinical and histologic features","volume":"71","author":"Moneta","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025110820513792500_keaf346-B8","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/brain\/awz207","article-title":"Highly differentiated cytotoxic T cells in inclusion body myositis","volume":"142","author":"Greenberg","year":"2019","journal-title":"Brain"},{"key":"2025110820513792500_keaf346-B9","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1212\/NXI.0000000000000558","article-title":"PD1 pathway in immune-mediated myopathies: pathogenesis of dysfunctional T cells revisited","volume":"6","author":"Knauss","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025110820513792500_keaf346-B10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00218-2","article-title":"Expression of IFN-gamma-inducible chemokines in inclusion body myositis","volume":"141","author":"Raju","year":"2003","journal-title":"J Neuroimmunol"},{"key":"2025110820513792500_keaf346-B11","doi-asserted-by":"crossref","first-page":"e88788","DOI":"10.1371\/journal.pone.0088788","article-title":"Th1 response and systemic Treg deficiency in inclusion body myositis","volume":"9","author":"Allenbach","year":"2014","journal-title":"PLoS One"},{"key":"2025110820513792500_keaf346-B12","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","article-title":"Differential expression of chemokines in inflammatory myopathies","volume":"58","author":"De Bleecker","year":"2002","journal-title":"Neurology"},{"key":"2025110820513792500_keaf346-B13","doi-asserted-by":"crossref","first-page":"e12957","DOI":"10.1111\/bpa.12957","article-title":"NanoString technology distinguishes anti-TIF-1gamma(+) from anti-Mi-2(+) dermatomyositis patients","volume":"31","author":"Preusse","year":"2021","journal-title":"Brain Pathol"},{"key":"2025110820513792500_keaf346-B14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard-2022-223792","article-title":"Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis","volume":"82","author":"Pinal-Fernandez","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025110820513792500_keaf346-B15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"2025110820513792500_keaf346-B16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"2025110820513792500_keaf346-B17","doi-asserted-by":"crossref","first-page":"e1193","DOI":"10.1212\/WNL.0000000000008128","article-title":"Identification of distinctive interferon gene signatures in different types of myositis","volume":"93","author":"Pinal-Fernandez","year":"2019","journal-title":"Neurology"},{"key":"2025110820513792500_keaf346-B18","doi-asserted-by":"crossref","first-page":"e000811","DOI":"10.1136\/rmdopen-2018-000811","article-title":"Distinct interferon signatures stratify inflammatory and dysimmune myopathies","volume":"5","author":"Rigolet","year":"2019","journal-title":"RMD Open"},{"key":"2025110820513792500_keaf346-B19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00401-021-02365-5","article-title":"A network of core and subtype-specific gene expression programs in myositis","volume":"142","author":"Amici","year":"2021","journal-title":"Acta Neuropathol"},{"key":"2025110820513792500_keaf346-B20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/ard-2024-225773","article-title":"Pathological autoantibody internalisation in myositis","volume":"83","author":"Pinal-Fernandez","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025110820513792500_keaf346-B21","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.41964","article-title":"Performance of the 2017 European Alliance of Associations for Rheumatology\/American College of Rheumatology classification criteria for idiopathic inflammatory myopathies in patients with myositis-specific autoantibodies","volume":"74","author":"Casal-Dominguez","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025110820513792500_keaf346-B22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","article-title":"Evaluation and construction of diagnostic criteria for inclusion body myositis","volume":"83","author":"Lloyd","year":"2014","journal-title":"Neurology"},{"key":"2025110820513792500_keaf346-B23","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025110820513792500_keaf346-B24","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.40883","article-title":"Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity","volume":"71","author":"Pinal-Fernandez","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025110820513792500_keaf346-B25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40478-017-0427-7","article-title":"Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis","volume":"5","author":"Amici","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"2025110820513792500_keaf346-B26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/ard-2023-223873","article-title":"Transcriptional derepression of CHD4\/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies","volume":"82","author":"Pinal-Fernandez","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025110820513792500_keaf346-B27","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1038\/ncomms8866","article-title":"A draft network of ligand\u2013receptor-mediated multicellular signalling in human","volume":"6","author":"Ramilowski","year":"2015","journal-title":"Nat Commun"},{"key":"2025110820513792500_keaf346-B28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","article-title":"Single-cell reconstruction of the early maternal\u2013fetal interface in humans","volume":"563","author":"Vento-Tormo","year":"2018","journal-title":"Nature"},{"key":"2025110820513792500_keaf346-B29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2013.10.021","article-title":"Identity crisis of Th17 cells: many forms, many functions, many questions","volume":"25","author":"Sundrud","year":"2013","journal-title":"Semin Immunol"},{"key":"2025110820513792500_keaf346-B30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"2025110820513792500_keaf346-B31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41423-019-0210-8","article-title":"Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses","volume":"16","author":"Gurram","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"2025110820513792500_keaf346-B32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2025110820513792500_keaf346-B33","author":"Pinal-Fernandez","year":"2025"},{"key":"2025110820513792500_keaf346-B34","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1038\/s41598-023-28838-z","article-title":"Coordinated local RNA overexpression of complement induced by interferon gamma in myositis","volume":"13","author":"Casal-Dominguez","year":"2023","journal-title":"Sci Rep"},{"key":"2025110820513792500_keaf346-B35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2019.02.003","article-title":"CD8+(T-bet+) cells as a predominant biomarker for inclusion body myositis","volume":"18","author":"Dzangue-Tchoupou","year":"2019","journal-title":"Autoimmun Rev"},{"key":"2025110820513792500_keaf346-B36","doi-asserted-by":"crossref","first-page":"e17240","DOI":"10.15252\/emmm.202217240","article-title":"Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathies","volume":"15","author":"Argyriou","year":"2023","journal-title":"EMBO Mol Med"},{"key":"2025110820513792500_keaf346-B37","doi-asserted-by":"crossref","first-page":"577833","DOI":"10.1016\/j.jneuroim.2022.577833","article-title":"Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy","volume":"365","author":"Oda","year":"2022","journal-title":"J Neuroimmunol"},{"key":"2025110820513792500_keaf346-B38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/art.40045","article-title":"Immune-array analysis in sporadic inclusion body myositis reveals HLA-DRB1 amino acid heterogeneity across the myositis spectrum","volume":"69","author":"Rothwell","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025110820513792500_keaf346-B39","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.0000000000003821","article-title":"Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients","volume":"88","author":"Lloyd","year":"2017","journal-title":"Neurology"},{"key":"2025110820513792500_keaf346-B40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis"},{"key":"2025110820513792500_keaf346-B41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.20649","article-title":"Myeloid dendritic cells in inclusion-body myositis and polymyositis","volume":"35","author":"Greenberg","year":"2007","journal-title":"Muscle Nerve"},{"key":"2025110820513792500_keaf346-B42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.micinf.2011.10.003","article-title":"XCL1 and XCR1 in the immune system","volume":"14","author":"Lei","year":"2012","journal-title":"Microbes Infect"},{"key":"2025110820513792500_keaf346-B43","doi-asserted-by":"crossref","first-page":"e2300343120","DOI":"10.1073\/pnas.2300343120","article-title":"XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors","volume":"120","author":"Heger","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025110820513792500_keaf346-B44","doi-asserted-by":"crossref","first-page":"852055","DOI":"10.3389\/fphar.2022.852055","article-title":"The expression of cytokine profiles and related receptors in idiopathic inflammatory myopathies","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025110820513792500_keaf346-B45","doi-asserted-by":"crossref","first-page":"1042580","DOI":"10.3389\/fneur.2022.1042580","article-title":"Comparison of cytokine\/chemokine profiles between dermatomyositis and anti-synthetase syndrome","volume":"13","author":"Wang","year":"2022","journal-title":"Front Neurol"},{"key":"2025110820513792500_keaf346-B46","first-page":"229","article-title":"Serum cytokine profiles of adults with idiopathic inflammatory myopathies","volume":"42","author":"Saygin","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"2025110820513792500_keaf346-B47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.21037\/atm-22-70","article-title":"Autophagy-related genes are potential diagnostic biomarkers for dermatomyositis","volume":"10","author":"Wang","year":"2022","journal-title":"Ann Transl Med"},{"key":"2025110820513792500_keaf346-B48","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/rheumatology\/kead654","article-title":"The emerging role of Growth Differentiation Factor 15 as a potential disease biomarker in juvenile dermatomyositis","volume":"64","author":"Duvvuri","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2025110820513792500_keaf346-B49","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.1780371206","article-title":"Elevated serum levels of interleukin-1 receptor antagonist in polymyositis\/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response","volume":"37","author":"Gabay","year":"1994","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf346\/63536727\/keaf346.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/11\/5751\/63536727\/keaf346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/11\/5751\/63536727\/keaf346.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:51:46Z","timestamp":1762653106000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/11\/5751\/8169939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6,20]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf346","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.02.17.25321047","asserted-by":"object"}]},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,6,20]]}}}